EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia

Zixing Lu iD, Yayi Liu, Zhaoqing Jiang, Yu Zhu iD, Wenjie Liu, Qian Sun, Lei Fan, Sixuan Qian, Ming Hong

Blood and Lymphatic Cancer: Targets and Therapy · 2026-07 · Volume 16 · 1-15

DOI: 10.2147/blctt.s621412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-07. Verfasst von Zixing Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People's Republic of Chi…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

High-dose idarubicinacute myeloid leukemiaautologous hematopoietic stem cell transplantation

Autor:innen und Institutionen

  • Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, People's Republic of China.
  • Key Laboratory of Hematology of Nanjing Medical University, Nanjing, People's Republic of China.
  • Department of Hematology, Ningbo Medical Centre Lihuili Hospital, Ningbo, Zhejiang, People's Republic of China.

ORCID-Profile: Zixing Lu, Yu Zhu

Zitieren

APA

Lu, Z., Liu, Y., Jiang, Z., Zhu, Y., Liu, W., Sun, Q., Fan, L., Qian, S., & Hong, M. (2026). Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-15. https://doi.org/10.2147/blctt.s621412

Vancouver

Lu Z, Liu Y, Jiang Z, Zhu Y, Liu W, Sun Q, et al. Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-15. doi:10.2147/blctt.s621412

BibTeX
@article{Lu2026,
  author = {Lu, Zixing and Liu, Yayi and Jiang, Zhaoqing and Zhu, Yu and Liu, Wenjie and Sun, Qian and Fan, Lei and Qian, Sixuan and Hong, Ming},
  title = {Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 16},
  pages = {1--15},
  doi = {10.2147/blctt.s621412}
}
Kostenlos starten →